Colorectal Neoplasms: Clinical Trials

9,380 trials for Colorectal Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4019 completed, 1826 unknown, 1389 recruiting, 756 terminated. 2617 Phase 2, 2551 Not applicable, 1610 Phase 1, 808 Phase 3, 154 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22617Completed 979, Unknown 480, Recruiting 396, Terminated 300, Active not recruiting 174, Not yet recruiting 155, Withdrawn 113, Suspended 15, Enrolling by invitation 5
Not applicable2551Completed 1153, Unknown 521, Recruiting 375, Not yet recruiting 159, Terminated 129, Active not recruiting 114, Withdrawn 62, Enrolling by invitation 31, Suspended 7
Phase 11610Completed 687, Recruiting 271, Terminated 255, Unknown 155, Active not recruiting 118, Not yet recruiting 60, Withdrawn 52, Suspended 11, Enrolling by invitation 1
Phase 3808Completed 322, Unknown 190, Recruiting 119, Terminated 65, Active not recruiting 58, Not yet recruiting 34, Withdrawn 14, Enrolling by invitation 3, Suspended 3
Phase 4154Completed 79, Unknown 37, Terminated 11, Not yet recruiting 10, Recruiting 10, Withdrawn 4, Active not recruiting 3
Early Phase 188Completed 22, Unknown 20, Recruiting 13, Terminated 10, Not yet recruiting 8, Active not recruiting 7, Withdrawn 5, Suspended 2, Enrolling by invitation 1

Follow Colorectal Neoplasms: new trials by email Literature Review of Colorectal Neoplasms trials Research Report on Colorectal Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
Shared Decision Making using a Patient Decision Aid. - Shared Decision Making, Colonic Polyp
Phase 2Not yet recruitingVejle Hospital1102028-02-012026-04-30
CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer
CA102N, TAS-102, Bevacizumab - Metastatic Colorectal Cancer
Phase 2SuspendedHoly Stone Healthcare Co., Ltd1002027-12-012026-09-18
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
intravoxel incoherent motion magnetic resonance imaging - Rectal Neoplasms, Prognosis
Not yet recruitingSichuan Cancer Hospital and Research Institute4002027-11-012025-12-08
SGA-OCRC: Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarians With Resectable Colorectal Cancer
Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine10002027-06-012026-10-29
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
Balstilimab, Biopsy Procedure, Biospecimen Collection - Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)202027-05-252026-09-29
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
PET/MRI in Rectal Cancer
Total Neo-adjuvant Therapy, 18FDG-PET/MRI scan - Rectal Cancer
Phase 2Not yet recruitingAHS Cancer Control Alberta402027-05-012026-10-28
Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options
Liver transplantation - Colorectal Neoplasms, Liver Neoplasms
Not applicableNot yet recruitingCharite University, Berlin, Germany2602027-04-012026-09-10
Cancer Awareness Among Syrian Migrants
PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening
Not applicableNot yet recruitingToros University302027-03-092026-10-15
Life Expectancy-informed Colorectal Cancer Screening
Decision Tool - Colorectal Cancer Control and Prevention
Not applicableNot yet recruitingKathryn Martinez150002027-03-012026-10-20
Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)] - Colon Cancer
Phase 2Not yet recruitingJohn Strickler, M.D.242027-03-012026-11-05
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Dietary Fiber, Enema Administration, Loperamide Hydrochloride - Low Anterior Resection Syndrome, Rectal Carcinoma
Not applicableRecruitingOhio State University Comprehensive Cancer Center802027-02-152026-10-06
OSCAR II STUDY - The ONCObind CTC Removal Study
ONCObind (Onco-Seraph) 100 Filter, Matched Controls - Pancreatic Ductal Adenocarcinoma (mPDAC), Metastatic Colorectal Carcinoma (mCRC)
Not applicableNot yet recruitingExThera Medical Corporation1202027-01-152026-04-17
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
ST316 IV - Familial Adenomatous Polyposis (FAP)
Phase 1Not yet recruitingSapience Therapeutics402027-01-042026-08-12
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma
Phase 3RecruitingCity of Hope Medical Center1292027-01-042026-11-05
Feasibility Study of Huangqi Yangyuan Formula for Capecitabine-Induced Adverse Reactions in Advanced Colorectal Cancer
Capecitabine, Huangqi Yangyuan Formula (Chinese Herbal Decoction) - Advanced Colorectal Cancer, Capecitabine-Related Adverse Reaction
Not applicableNot yet recruitingHuanfang Fan352027-01-012026-11-03
Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC
Panitumumab N01, Cetuximab (EGFR inhibitor) - Colorectal Cancer Metastatic
Not yet recruitingFujian Medical University Union Hospital6102027-01-012026-11-04
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
Cemiplimab - Colon and Rectal Cancer
Phase 2RecruitingColumbia University202027-01-012026-11-04
Alberta Cancer Exercise Dose in Colorectal Cancer
Group Exercise Classes - Arm 1, Group Exercise Classes - Arm 2 - Cancer, Colorectal Cancer
Phase 2Not yet recruitingUniversity of Calgary902027-01-012026-11-06

Showing 20 of 9380. Sign in to see all of them.

Narrower conditions

Colonic Neoplasms (2382)  ·  Rectal Neoplasms (2245)  ·  Breast Neoplasms (806)  ·  Neoplasms (652)  ·  Pancreatic Neoplasms (618)  ·  Stomach Neoplasms (548)  ·  Carcinoma, Non-Small-Cell Lung (530)  ·  Neoplasm Metastasis (493)  ·  Lung Neoplasms (479)  ·  Ovarian Neoplasms (412)  ·  Prostatic Neoplasms (377)  ·  Melanoma (304)  ·  Anus Neoplasms (296)  ·  Esophageal Neoplasms (296)

Broader conditions

Digestive System Diseases (9338)  ·  Neoplasms by Site (9337)  ·  Intestinal Diseases (9329)  ·  Gastrointestinal Diseases (9328)  ·  Digestive System Neoplasms (9316)  ·  Intestinal Neoplasms (9312)  ·  Gastrointestinal Neoplasms (9187)  ·  Neoplasms (8728)  ·  Rectal Diseases (7940)  ·  Colonic Diseases (7874)  ·  Pathological Conditions, Signs and Symptoms (1618)  ·  Neoplasms by Histologic Type (1238)  ·  Pathologic Processes (1190)  ·  Urogenital Diseases (1101)

Interventions

Fluorouracil (669)  ·  Oxaliplatin (650)  ·  Bevacizumab (561)  ·  Leucovorin (547)  ·  Capecitabine (531)  ·  Irinotecan (489)  ·  Cetuximab (392)  ·  Radiotherapy (189)  ·  pembrolizumab (181)  ·  Folfox protocol (166)  ·  Panitumumab (137)  ·  Drug Therapy (134)  ·  Colonoscopy (121)  ·  regorafenib (118)  ·  Nivolumab (107)

Sponsors

National Cancer Institute (NCI) (215)  ·  Fudan University (148)  ·  Sun Yat-sen University (131)  ·  M.D. Anderson Cancer Center (125)  ·  Memorial Sloan Kettering Cancer Center (106)  ·  Hoffmann-La Roche (87)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (69)  ·  City of Hope Medical Center (63)  ·  Pfizer (55)  ·  Assistance Publique - Hôpitaux de Paris (54)  ·  Alliance for Clinical Trials in Oncology (51)  ·  Massachusetts General Hospital (47)  ·  Chinese University of Hong Kong (46)  ·  Eli Lilly and Company (45)  ·  Amgen (42)

Countries

United States (3180)  ·  China (1533)  ·  France (776)  ·  Spain (580)  ·  Italy (563)  ·  United Kingdom (495)  ·  Canada (477)  ·  Germany (439)  ·  South Korea (384)  ·  Netherlands (330)  ·  Belgium (316)  ·  Australia (268)  ·  Denmark (266)  ·  Taiwan (209)  ·  Sweden (206)

Top investigators

Norman Wolmark, MD (21)  ·  Ajay Goel, PhD (13)

Results publications

PMID 36306483, PMID 15496622, PMID 35588252, PMID 37162250, PMID 31268130, PMID 33356421, PMID 26049686, PMID 26187751, PMID 28712102, PMID 30679026, PMID 31378656, PMID 32816630, PMID 18316791, PMID 19269519, PMID 19339720, PMID 21596621, PMID 21997132, PMID 22070868, PMID 26808342, PMID 32085892, PMID 33538338, PMID 33657038, PMID 36748942, PMID 37310167, PMID 37934000, PMID 38592721, PMID 42681563, PMID 15894098, PMID 16971718, PMID 17976611, PMID 20106720, PMID 22067400, PMID 22529255, PMID 23008301, PMID 23395398, PMID 23493136, PMID 23578724, PMID 25071111, PMID 26156652, PMID 26348120, PMID 26438146, PMID 27432417, PMID 27432930, PMID 27602924, PMID 27986363, PMID 28223062, PMID 29627309, PMID 30025745, PMID 30207593, PMID 30936547

NIH funding

2023 (55), 2025 (48), 2017 (36), 2016 (32), 2019 (32), P30CA033572 (32), 2009 (28), 2018 (28), 2015 (26), P30CA015083 (25), P30CA014089 (22), 2008 (20), 2014 (17), P30CA016672 (16), P30CA068485 (15)